Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
Open Access
- 1 October 1979
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 150 (4) , 862-877
- https://doi.org/10.1084/jem.150.4.862
Abstract
We tested the ability of pepsin-extracted, highly purified M protein to induce type-specific immunity in experimental animals and humans. M protein was prepared from limited peptic digests of whole group A type 24 streptococci and was purified to chemical homogeneity as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, quantitative amino acid analysis, and Edman degradation. For vaccination, the lyophilized M24 protein preparation (pep M24) was precipitated in aluminum hydroxide. When injected into laboratory animals, alum-precipitated pep M24 produced type-specific protective antibodies and was free of non-type-specific immunoreactivity. In man, skin tests with 1-microgram doses of pep M24 were negative in all 37 adults tested. 12 adult human volunteers received two-four subcutaneous injections of 100-200 micrograms of alum-precipitated pep M24 at intervals of at least 2 wk. The immune response to pep M24 was measured by a variety of assays designed to detect (a) type-specific humoral antibodies (opsonophagocytic, long chain, and mouse protection tests); (b) total humoral antibodies (complement fixation and enzyme-linked immunosorbent assay); (c) cellular immunity (skin tests); and (d) heart cross-reactive antibodies (immunofluorescence). Type-specific opsonic antibodies developed in 10 of the 12 vaccinees, and positive delayed-type skin tests developed in 11. Immune sera from two of the vaccinees were effective in mouse-protection tests against challenge with M24 but not M6 streptococci. None of the volunteers developed heart-reactive antibodies or antibodies to non-type-specific M protein antigens. Alum-precipitated pep M24 was well-tolerated in man, and no serious local or systemic reactions were observed. Thus, pep M24 induces type-specific, protective antibodies in doses that are well-tolerated in man.This publication has 37 references indexed in Scilit:
- Protective Studies with Group A Streptococcal M Protein Vaccine. III. Challenge of Volunteers after Systemic or Intranasal Immunization with Type 3 or Type 12 Group A StreptococcusThe Journal of Infectious Diseases, 1978
- Repeating covalent structure of streptococcal M protein.Proceedings of the National Academy of Sciences, 1978
- Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule.The Journal of Experimental Medicine, 1977
- Group a streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigenThe Journal of Experimental Medicine, 1977
- Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigenThe Journal of Experimental Medicine, 1977
- Separation of the type specific M protein from toxic cross reactive antigens of group A streptococci.1977
- Basophils in tuberculin and "Jones-Mote" delayed reactions of humans.Journal of Clinical Investigation, 1976
- Immunochemical Properties of Streptococcal M Protein Purified by Isoelectric FocusingThe Journal of Immunology, 1975
- The relative rheumatogenicity of strains of group A streptococci.1975
- Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.1972